This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 Apr 5;123(13):1436-50.

doi: 10.1161/CIRCULATIONAHA.110.004424.

Dabigatran etexilate: a new oral thrombin inhibitor

Graeme J Hankey¹, John W Eikelboom

Affiliations

PMID: 21464059
DOI: 10.1161/CIRCULATIONAHA.110.004424

Review

Dabigatran etexilate: a new oral thrombin inhibitor

Graeme J Hankey et al. Circulation. 2011.

. 2011 Apr 5;123(13):1436-50.

doi: 10.1161/CIRCULATIONAHA.110.004424.

Authors

Graeme J Hankey¹, John W Eikelboom

Affiliation

¹ Department of Neurology, Royal Perth Hospital, 197 Wellington St, Perth, Australia 6001. gjhankey@cyllene.uwa.edu.au

PMID: 21464059
DOI: 10.1161/CIRCULATIONAHA.110.004424

No abstract available

PubMed Disclaimer

Similar articles

Dabigatran etexilate (Pradaxa)--a new oral anticoagulant.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Nov 15;52(1351):89-90. Med Lett Drugs Ther. 2010. PMID: 21068702 Review.
Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin.
Eisert WG, Hauel N, Stangier J, Wienen W, Clemens A, van Ryn J. Eisert WG, et al. Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1885-9. doi: 10.1161/ATVBAHA.110.203604. Epub 2010 Jul 29. Arterioscler Thromb Vasc Biol. 2010. PMID: 20671233 Review.
Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.
Stangier J, Clemens A. Stangier J, et al. Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S. doi: 10.1177/1076029609343004. Epub 2009 Aug 19. Clin Appl Thromb Hemost. 2009. PMID: 19696042 Review.
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].
Gassanov N, Caglayan E, Erdmann E, Er F. Gassanov N, et al. Dtsch Med Wochenschr. 2010 Feb;135(6):256-9. doi: 10.1055/s-0030-1247864. Epub 2010 Jan 26. Dtsch Med Wochenschr. 2010. PMID: 20104442 Review. German. No abstract available.
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN).
Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB, Härtter S, Harper R, Kappetein AP, Lehr T, Mack MJ, Noack H, Eikelboom JW. Van de Werf F, et al. Am Heart J. 2012 Jun;163(6):931-937.e1. doi: 10.1016/j.ahj.2012.03.011. Am Heart J. 2012. PMID: 22709744 Clinical Trial.

See all similar articles

Cited by

Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE^-/--LDLR^-/- Double-Knockout Mice.
Sanda T, Yoshimura M, Hyodo K, Ishii H, Yamashita T. Sanda T, et al. Korean Circ J. 2020 Sep;50(9):804-816. doi: 10.4070/kcj.2020.0055. Epub 2020 Jun 15. Korean Circ J. 2020. PMID: 32725990 Free PMC article.
Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis.
Van Den Helm S, Sparks CN, Ignjatovic V, Monagle P, Attard C. Van Den Helm S, et al. Front Pediatr. 2022 Mar 28;10:803408. doi: 10.3389/fped.2022.803408. eCollection 2022. Front Pediatr. 2022. PMID: 35419321 Free PMC article.
Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.
Kustos SA, Fasinu PS. Kustos SA, et al. Medicines (Basel). 2019 Oct 15;6(4):103. doi: 10.3390/medicines6040103. Medicines (Basel). 2019. PMID: 31618893 Free PMC article. Review.
Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.
Meyer Dos Santos S, Harder S. Meyer Dos Santos S, et al. Drug Saf. 2014 May;37(5):295-307. doi: 10.1007/s40264-014-0151-1. Drug Saf. 2014. PMID: 24683059 Review.
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function.
Maw TT, Henry BL, Singh T. Maw TT, et al. Clin Nephrol Case Stud. 2014 Aug 20;2:18-22. doi: 10.5414/CNCS108253. eCollection 2014. Clin Nephrol Case Stud. 2014. PMID: 29043124 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database